Skip to content

Clinical trials

Completed Cardiovascular Diseases trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Status: Completed Country / region: Czechia Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20061
20082
20094
20101
20112
20126
20132
20144
20153
20162
20171
20183
20192
20211
20223
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline5
Novartis Pharmaceuticals5
Abbott Medical Devices4
Amgen2
Boston Scientific Corporation2
Cardurion Pharmaceuticals, Inc.2
Eli Lilly and Company2
Hoffmann-La Roche2
AstraZeneca1
Bayer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases44
Heart Diseases13
Heart Failure11
Myocardial Infarction6
Ventricular Dysfunction6
Atherosclerosis5
Atrial Fibrillation5
Diabetes Mellitus, Type 25
Hypertension5
Acute Coronary Syndrome4

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.